2Martin B, Paesmans M, Mascaux C, et al. Ki-67 expression and patients survival in tung cancer: Systematic review of the literature with meta analysis[J]. Br J Cancer, 2004,91 : 2 108-2 025.
4Marchetti A ,Bretacca G,Buttitta F,et al. Telomerase activity as a prognostic indicator in stage Ⅰ non small cell lung cancer[J]. Clin Cancer Res,1999,15(8):2 077-2 081.
5Nakamura H,Kawasaki N, Taguchi M,et al. Association of HER-2 overexpression with prognosis in non-small cell lung carcinoma: A me ta analysis[J]. Cancer,2005,103: 1 865 - 1 873.
7Martin B, Paesmans M,Berghmans T,et al. Role of Bcl-2 as a prog nostic factor for survival in lung cancer : A systematic review of the literature with meta-analysis[J]. Br J Cancer, 2003,89 : 55-64.
2[7]Andrade F, Roy S, Nicholson D, et al. Granzyme B directly and efficiently cleaves several downstreem caspase substrates: implications for CTL-induced apoptosis. Immunity,1998,8(4)∶451-460.
3[8]Sarela AI, Macadam RC, Farmery SM, et al. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut,2000,46(5)∶645-650.
4[10]Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol,1998,152(1)∶43-49.
5[1]Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med,1997,3(8)∶917-921.
6[2]Grossman D, McNiff JM, Li F, et al. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest,1999,79(9)∶1121-1126.
7[3]Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res,2000,6(1)∶127-134.
8[5]Keer JFR, Winterford CM, Harman BV. Apoptosis, its significance in carcinoma and carcinoma therapy. Carcinoma,1994,73(3)∶2013-2017.
9[6]LaCasse EC, Baird S, Korneluk RG, et al. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene,1998,17(25)∶3247-3259.
10Glondu M,Liaudet CE,Derocq D,et al.Down regulation of cathepsin D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells[J].Oncogene,2002,21(33):5127
3Levy M, Visokai V, Lipska L, et al. Tumor markers in staging and prognosis of colorectal carcinoma. Neoplasma, 2008,55 ( 2 ) : 138- 142.
4Buccheri G, Ferrigno D. Lung tumor markers in onlogypractice: a study of TPA and CA125. Br J Cancer, 2002,87 (10) : 1112 - 1118.
5Herbst RS, Heymach JV, Lippman SM. Lung cancel , N Engl J Med,2008,359 (13) :1367-1380.
6Han M, Liu Q, Yu J, et al. Detection and significance of serum pro- tein markers of small-cell lung cancer. J Clin Lab Anal,2008,22 (2) : 131-137.
7Vinolas N , Molina R, Casas F, et al. Tumor markers in response monitoring and prognosis of non small cell lung cancer: prelimina- ry report. Anticancer Res, 1998,18 ( 1 B ) :631-634.
